ClinicalTrials.Veeva

Menu

Cannabis Reduction and Functional Outcomes

Medical University of South Carolina (MUSC) logo

Medical University of South Carolina (MUSC)

Status

Begins enrollment in 1 month

Conditions

Cannabis Use Disorder

Treatments

Behavioral: CBT4CBT (Computerized Cognitive Behavioral Therapy)
Behavioral: Contingency Management
Behavioral: Motivational Interviewing

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07218471
NIDA R01 DA062443 (Other Grant/Funding Number)
Pro00145652

Details and patient eligibility

About

This study evaluates the effects of cannabis use reduction among adults diagnosed with cannabis use disorder (CUD). Participants will undergo an 8-week intervention combining motivational interviewing, computerized cognitive behavioral therapy (CBT4CBT), and financial incentives for reduction in urinary cannabinoids. The study aims to assess improvements in cannabis-related problems, sleep, cognitive performance, CUD severity, and quality of life.

Enrollment

176 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18+
  • Urinary cannabinoid level ≥ 50 ng/mL
  • DSM-5 diagnosis of CUD (mild, moderate, or severe)
  • Willingness to attempt cannabis reduction
  • Completion of Intake Visit

Exclusion criteria

  • Serious medical/psychiatric conditions
  • Pregnancy or breastfeeding
  • Use of cannabis in past 30 days was for medical purposes only
  • Discontinuation or reduction of cannabis use may exacerbate a pre-existing condition
  • TICS score ≤ 19

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Central trial contact

Rachel Tomko, PhD; Erin McClure, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems